Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Thomassen

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Vaccine|July 25, 2019
Accelerating bioprocess development by analysis of all available data: A USP case studyDiego A Suarez-Zuluaga, Daniel Borchert, Nicole N Driessen, et al.
Bioprocess and Biosystems Engineering|October 9, 2014
Mathematical model of adherent Vero cell growth and poliovirus production in animal component free mediumRamona V Ursache, Yvonne E Thomassen, Gerco van Eikenhorst, et al.
Biotechnology and Bioengineering|May 28, 2010
Multivariate data analysis on historical IPV production data for better process understanding and future improvementsYvonne E Thomassen, Eric N M van Sprang, Leo A van der Pol, et al.
Vaccine|March 4, 2014
Improved poliovirus D-antigen yields by application of different Vero cell cultivation methodsYvonne E Thomassen, Olaf Rubingh, René H Wijffels, et al.
Process Biochemistry (Barking, London, England)|June 21, 2019
Kinetic model for adherent Vero cell growth and poliovirus production in batch bioreactorsYang Jiang, Joyce E van der Welle, Olaf Rubingh, et al.
Vaccine: X|October 11, 2022
Development of an animal component free production process for Sabin inactivated polio vaccineDiego A Suarez-Zuluaga, Leo A van der Pol, Aart G van 't Oever, et al.
Biologicals : Journal of the International Association of Biological Standardization|December 14, 2011
Development of a fast ELISA for quantifying polio D-antigen in in-process samplesR ten Have, Y E Thomassen, M R J Hamzink, et al.
Biotechnology and Bioengineering|November 30, 2012
Scale-down of the inactivated polio vaccine production processYvonne E Thomassen, Aart G van 't Oever, Marian Vinke, et al.
Plos One|December 19, 2013
Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goalsYvonne E Thomassen, Aart G van 't Oever, Monique G C T van Oijen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 21, 2021
Mental health indicators in pregnant women compared with women in the general population during the coronavirus disease 2019 pandemic in DenmarkElin R Severinsen, Lise K A Kähler, Sofie E Thomassen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Vaccine|July 25, 2019
Accelerating bioprocess development by analysis of all available data: A USP case studyDiego A Suarez-Zuluaga, Daniel Borchert, Nicole N Driessen, et al.
Bioprocess and Biosystems Engineering|October 9, 2014
Mathematical model of adherent Vero cell growth and poliovirus production in animal component free mediumRamona V Ursache, Yvonne E Thomassen, Gerco van Eikenhorst, et al.
Biotechnology and Bioengineering|May 28, 2010
Multivariate data analysis on historical IPV production data for better process understanding and future improvementsYvonne E Thomassen, Eric N M van Sprang, Leo A van der Pol, et al.
Vaccine|March 4, 2014
Improved poliovirus D-antigen yields by application of different Vero cell cultivation methodsYvonne E Thomassen, Olaf Rubingh, René H Wijffels, et al.
Process Biochemistry (Barking, London, England)|June 21, 2019
Kinetic model for adherent Vero cell growth and poliovirus production in batch bioreactorsYang Jiang, Joyce E van der Welle, Olaf Rubingh, et al.
Vaccine: X|October 11, 2022
Development of an animal component free production process for Sabin inactivated polio vaccineDiego A Suarez-Zuluaga, Leo A van der Pol, Aart G van 't Oever, et al.
Biologicals : Journal of the International Association of Biological Standardization|December 14, 2011
Development of a fast ELISA for quantifying polio D-antigen in in-process samplesR ten Have, Y E Thomassen, M R J Hamzink, et al.
Biotechnology and Bioengineering|November 30, 2012
Scale-down of the inactivated polio vaccine production processYvonne E Thomassen, Aart G van 't Oever, Marian Vinke, et al.
Plos One|December 19, 2013
Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goalsYvonne E Thomassen, Aart G van 't Oever, Monique G C T van Oijen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 21, 2021
Mental health indicators in pregnant women compared with women in the general population during the coronavirus disease 2019 pandemic in DenmarkElin R Severinsen, Lise K A Kähler, Sofie E Thomassen, et al.
Pageof 5